NFE2L2 and early-onset autosomal dominant Alzheimer disease: Immunohistochemistry analysis of brains from AD (Alzheimer ́s disease) patients suggests a blockage of Nrf2 nuclear translocation and, consequently, lower Nrf2 transcriptional activity7.